Aberdeen Group’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$536K Sell
29,655
-127
-0.4% -$2.42K ﹤0.01% 875
2025
Q4
$647K Buy
29,782
+11,456
+63% +$328K ﹤0.01% 864
2025
Q3
$598K Buy
18,326
+4,178
+30% +$154K ﹤0.01% 880
2025
Q2
$502K Sell
14,148
-638
-4% -$20.7K ﹤0.01% 883
2025
Q1
$502K Sell
14,786
-16,732
-53% -$600K ﹤0.01% 872
2024
Q4
$1.03M Sell
31,518
-2,211
-7% -$91.6K ﹤0.01% 821
2024
Q3
$1.63M Buy
33,729
+17,696
+110% +$943K ﹤0.01% 770
2024
Q2
$710K Buy
16,033
+2,464
+18% +$114K ﹤0.01% 837
2024
Q1
$761K Sell
13,569
-2,132
-14% -$129K ﹤0.01% 842
2023
Q4
$945K Buy
15,701
+2,441
+18% +$155K ﹤0.01% 841
2023
Q3
$891K Sell
13,260
-2,343
-15% -$163K ﹤0.01% 769
2023
Q2
$1.08M Buy
15,603
+2,702
+21% +$177K ﹤0.01% 787
2023
Q1
$622K Sell
12,901
-664
-5% -$32.5K ﹤0.01% 823
2022
Q4
$677K Buy
13,565
+3,990
+42% +$193K ﹤0.01% 809
2022
Q3
$391K Buy
9,575
+4,222
+79% +$198K ﹤0.01% 863
2022
Q2
$295K Buy
+5,353
New +$226K ﹤0.01% 909

Other funds holding LEGN